-
Taxonomy & unit
-
ifrs-full: CAD
-
Summary
-
ImmunoPrecise Antibodies Ltd. quarterly/annual Research And Development Expense history and growth rate from Q3 2022 to Q4 2023.
- ImmunoPrecise Antibodies Ltd. Research And Development Expense for the quarter ending January 31, 2024 was CA$1M, a 36% decline year-over-year.
- ImmunoPrecise Antibodies Ltd. annual Research And Development Expense for 2022 was CA$12.3M, a 60.3% increase from 2021.
- ImmunoPrecise Antibodies Ltd. annual Research And Development Expense for 2021 was CA$7.66M, a 288% increase from 2020.
- ImmunoPrecise Antibodies Ltd. annual Research And Development Expense for 2020 was CA$1.97M, a 343% increase from 2019.
Research And Development Expense, Quarterly (CAD)
Research And Development Expense, YoY Quarterly Growth (%)